Kardigan, Inc.KARD

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$14.39
Market cap
$1.3B
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
—
Debt / equity
—

What Kardigan, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year20242025

More on KARD.

Figures from Kardigan, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.